Skip to main content

Table 3 Frequency of autoantibody against SPP1 in human serum by ELISA

From: Serum anti-SPP1 autoantibody as a potential novel biomarker in detection of esophageal squamous cell carcinoma

 

Serum

N (%)

P

Discovery group

ESCC(n = 62)

28(45.16%)

 < 0.001

NC(n = 62)

10(16.13%)

Validation group

ESCC(n = 100)

41(41.00%)

 < 0.001

NC(n = 100)

13(13.00%)

  1. ESCC Esophageal squamous cell carcinoma, NC Normal controls